Skip to main content
SpringerLink
Log in

Therapeutische Konzepte bei CFS/FMS unter besonderer Berücksichtigung der Anwendung von Naturheilverfahren

  • Chapter
Chronisches Müdigkeits- und Fibromyalgiesyndrom

  • 35 Accesses

Zusammenfassung

Der folgende Überblick ist gegründet auf meine mehrjährige klinische Tätigkeit als Funktionsoberarzt (CvK) in der Klinik Höhenkirchen im Klinikverbund des Münchener Modells der Ludwig-Maximilians-Universität München. Während dieser Zeit wurde eine große Anzahl von Patienten mit verschiedenen Schweregraden des CFS und der Übergangssyndrome zur Fibromyalgie bzw. zur psychovegetativen Erschöpfung (nach der früheren Nomenklatur) gemeinsam interdisziplinär betreut. Da die Patienten während dieser Zeit mindestens 4 Wochen, in Einzelfällen sogar bis zu 3 Monaten, stationär behandelt wurden, ergaben sich hierbei Möglichkeiten zur Beobachtung, die in der niedergelassenen Praxis bzw. unter poliklinischer Betreuung kaum möglich sind.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Behan PO, Behan WMH, Horrobin D (1990) Effect of high doses of essential fatty acids on the postviral fatigue syndrome. Acta Neurol Scand 82: 209–216

    Article  PubMed  CAS  Google Scholar 

  2. Cater RE (1995) Chronic intestinal candidiasis as a possible etiological factor in the chronic fatigue syndrome. Med Hypotheses 44: 507–515

    Article  PubMed  Google Scholar 

  3. Chalder T, Wallace P, Wessley S (1997) Self-help treatment of chronic fatigue in the community: A randomized controlled trial. Br J Health Psychol 2: 189–197

    Article  Google Scholar 

  4. Deale A, Chalder T, Marks I, Wessley S (1997) Cognitive behavior therapy for chronic fatigue syndrome: A randomized controlled trial. Am J Psychiatr 154: 408–414

    PubMed  CAS  Google Scholar 

  5. Demitrack MA, Dale JK, Straus SE et al. (1991) Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 73(6): 1224–1234

    Article  PubMed  CAS  Google Scholar 

  6. DeVinci C, Levine PH, Pizza G et al. (1996) Lessons from a pilot study of transfer factor in chronic fatigue syndrome. Biotherapy 9: 87–90

    Article  CAS  Google Scholar 

  7. Doepel LK (1996) Steroid fails to adequately relieve symptoms of chronic fatigue syndrome. NIH News Release, National Institute of Allergy and Infectious Diseases

    Google Scholar 

  8. Gray JB, Martinovic AM (1994) Eicosanoids and essential fatty acid modulation in chronic disease and the chronic fatigue syndrome [published erratum appears in Med Hypotheses 1995 Aug; 45(2): 219]. Med Hypotheses 43: 31–42

    Article  PubMed  CAS  Google Scholar 

  9. Hana I, Vrubel J, Pekarek J, Cech K (1996) The influence of age on transfer factor treatment of cellular immunodeficiency, chronic fatigue syndrome and/or chronic viral infections. Biotherapy 9 (1–3): 91–95

    Article  PubMed  CAS  Google Scholar 

  10. Jacobson SK, Daly JS, Thorne GM, McIntosh K (1997) Chronic parvovirus B19 infection resulting in chronic fatigue syndrome: Case history and review. Clin Infect Dis 24: 1048–1051

    Article  PubMed  CAS  Google Scholar 

  11. Kodama M, Kodama T, Murakami M (1996) The value of the dehydroepiandrosteroneannexed vitamin C infusion treatment in the clinical control of chronic fatigue syndrome (CFS). I. A pilot study of the new vitamin C infusion treatment with a volunteer CFS patient. In Vivo (Attiki) 10: 575 – 584

    CAS  Google Scholar 

  12. Kodama M, Kodama T, Murakami M (1996) The value of the dehydroepiandrosteroneannexed vitamin C infusion treatment in the clinical control of chronic fatigue syndrome (CFS). II. Characterization of CFS patients with special reference to their response to a new vitamin C infusion treatment. In Vivo (Attiki) 10: 585 – 596

    CAS  Google Scholar 

  13. Lerner AM, Zervos M, Dworkin HJ et al. (1997) New cardiomyopathy: Pilot study of intravenous ganciclovir in a subset of the chronic fatigue syndrome. Infect Dis Clin Pract 6: 110–117

    Article  Google Scholar 

  14. Natelson BH, Cheu J, Hill N et al. (1998) Single-blind, placebo phase-in trial of two ecalating doses of selegiline in the chronic fatigue syndrome. Neuropsychobiology 37: 150 – 154

    Article  PubMed  CAS  Google Scholar 

  15. Natelson BH, Cheu J, Pareja J et al. (1996) Randomized, double blind, controlled placebophase in trial of low dose phenelzine in the chronic fatigue syndrome. Psychopharmacology 14: 226 – 230

    Article  Google Scholar 

  16. Plioplys AV, Plioplys S (1997) Amantadine and L-carnitine treatment of chronic fatigue syndrome. Neuropsychobiology 35(1): 16–23

    Article  PubMed  CAS  Google Scholar 

  17. Raslow JE, Rucker L, Onishi R (1989) Bovine liver extract containing folic acid and cyanocobalamin (LEFAC). Arch Intern Med 149: 2501–2503

    Article  Google Scholar 

  18. Rowe KS (1997) Double-blind randomized controlled trial to assess the efficacy of intravenous gammaglobulin for the management of chronic fatigue syndrome in adolescents. J Psychiatr Res 31: 133–147

    Article  PubMed  CAS  Google Scholar 

  19. See DM, Broumand N, Sahl L, Tilles JG (1997) In vitro effects of echinacea and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients. Immunopharmacology 35: 229 – 235

    Article  PubMed  CAS  Google Scholar 

  20. Sharpe M (1997) Cognitive behavior therapy for functional somatic complaints. The example of chronic fatigue syndrome. Psychosomatics 38: 356–362

    Article  PubMed  CAS  Google Scholar 

  21. Straus SE, Dale JK, Tobi M et al. (1988) Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trial. N Engl J Med 319(26): 1692–1698

    Article  PubMed  CAS  Google Scholar 

  22. Strayer DR, Carter WA, Brodsky I et al. (1994) A controlled clinical trial with a specifically configured RNA drug, poly(I).poly(C12 U), in chronic fatigue syndrome. Clin Infect Dis 18 (Suppl 1): 88–95

    Article  Google Scholar 

  23. Suhadolnik RJ, Reichenbach NL, Hitzges PM et al. (1993) RNA drug therapy acting via the 2–5A synthetase/RNase L pathway. Ann NY Acad Sci 685: 756 – 757

    Article  PubMed  CAS  Google Scholar 

  24. Suhadolnik RJ, Reichenbach NL, Hitzges PM et al. (1994) Upregulation of the 2 – 5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome. Clin Infect Dis 18 (Suppl 1): 96–104

    Article  Google Scholar 

  25. Vollmer CU, Hickie I, Hadzi PD et al. (1997) Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome. Am J Med 103: 38 – 43

    Article  Google Scholar 

  26. White PD, Cleary KJ (1997) An open study of the efficacy and adverse effects of moclobemide in patients with the chronic fatigue syndrome. Int Clin Psychopharmacol 12: 47–52

    Article  PubMed  CAS  Google Scholar 

  27. Wilson A, Hickie I, Lloyd A et al. (1994) Longitudinal study of outcome of chronic fatigue syndrome (see comments). Br Med J 308: 756–759

    Article  CAS  Google Scholar 

Download references

Authors
  1. C. von Keudell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Worku
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. R. Meier
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Jeschke
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinische Klinik und Poliklinik, Abteilung Innere Medizin II, Universität Tübingen, Otfried-Müller-Straße 10, D-72076, Tübingen, Deutschland

    Peter A. Berg

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

von Keudell, C., Worku, F., Meier, G.R., Jeschke, D. (1999). Therapeutische Konzepte bei CFS/FMS unter besonderer Berücksichtigung der Anwendung von Naturheilverfahren. In: Berg, P.A. (eds) Chronisches Müdigkeits- und Fibromyalgiesyndrom. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-00574-3_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-00574-3_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-65093-5

  • Online ISBN: 978-3-662-00574-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation